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Abstract
Background: Children presenting to hospital with recent or current Plasmodium falciparum malaria are at increased
the risk of invasive bacterial disease, largely enteric gram-negative organisms (ENGO), which is associated with
increased mortality and recurrent morbidity. Although incompletely understood, the most likely source of EGNO is
the bowel. We hypothesised that as a result of impaired gut-barrier function endotoxin (lipopolysaccharide), present
in the cell-wall of EGNO and in substantial quantities in the gut, is translocated into the bloodstream, and
contributes to the pathophysiology of children with severe malaria.
Methods: We conducted a prospective study in 257 children presenting with malaria to two hospitals in Kenya and
Uganda. We analysed the clinical presentation, endotoxin and cytokine concentration.
Results: Endotoxaemia (endotoxin activity ≥0.4 EAA Units) was observed in 71 (27.6%) children but its presence
was independent of both disease severity and outcome. Endotoxaemia was more frequent in children with severe
anaemia but not specifically associated with other complications of malaria. Endotoxaemia was associated with a
depressed inflammatory and anti-inflammatory cytokine response. Plasma endotoxin levels in severe malaria
negatively correlated with IL6, IL10 and TGFβ (Spearman rho: TNFα: r=−0.122, p=0.121; IL6: r=−0.330, p<0.0001; IL10:
r=−0.461, p<0.0001; TGFβ: r=−0.173, p<0.027).
Conclusions: Endotoxaemia is common in malaria and results in temporary immune paralysis, similar to that
observed in patients with sepsis and experimentally-induced endotoxaemia. Intense sequestration of P. falciparum-
infected erythrocytes within the endothelial bed of the gut has been observed in pathological studies and may
lead to gut-barrier dysfuction. The association of endotoxaemia with the anaemia phenotype implies that it may
contribute to the dyserythropoesis accompanying malaria through inflammation. Both of these factors feasibly
underpin the susceptibility to EGNO co-infection. Further research is required to investigate this initial finding, with
a view to future treatment trials targeting mechanism and appropriate antimicrobial treatment.
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Background
Endotoxin is a complex lipopolysaccharide (LPS) present
in the cell walls of gram-negative bacteria and in sub-
stantial quantities in the bowel, and a potent trigger of
innate immunity due to activation of Toll Like Receptor
(TLR) signalling [1]. The effects of endotoxin in sepsis
are wide ranging, including upregulation of endothelial
cytoadherence receptors [2], anaemia and various meta-
bolic disturbances such as acidosis and hypoglycaemia.
Endotoxin acts as a potent stimulus for the release of
pro-inflammatory cytokines such as TNFα, IL1 and IL6
that have been implicated in the pathophysiology of se-
vere infectious diseases, including malaria. Nevertheless,
establishing the relationship between endotoxaemia and
infection has been frustrated by the limitations of avail-
able endotoxin assays [3]. In adults with critical illness,
recent studies have shown that endotoxaemia is associ-
ated with mortality, organ failure and prolonged inten-
sive care unit admission [4]. In children, endotoxaemia
has been associated with more severe illness requiring
admission to intensive care, severity or duration of ill-
ness but not mortality [5,6].
Severe forms of Plasmodium falciparum malaria are
characterised be excessive inflammation, organ damage
and metabolic dysregulation, a picture similar to that ob-
served in patients suffering from severe bacterial sepsis
[7]. Malaria infection strongly predisposes African chil-
dren to invasive bacterial disease (IBD). Whilst the epi-
demiological data supporting this causal link are robust
the mechanism for this association remains obscure.
The leading causes of IBD in P. falciparum infection are
non-typhoidal Salmonellae (NTS), E. coli and other en-
teric organisms with gram-negative organisms (EGNO)
becoming increasingly more predominant across the se-
verity spectrum: from those with evidence of recent mal-
aria infection (slide negative, Paracheck-PfW positive),
intercurrent malaria and greatest in those with severe
malaria and hyperparasitaemia [8-12]. Although the
mechanisms underlying the increased susceptibility are
uncertain, they may include disordered gut barrier func-
tion secondary to intense sequestration of parasitized
red cells in the intestine [13-15] and/or acute severe per-
fusion injury secondary to severe anaemia (haemoglobin
< 5 g/dl) and shock. A recent study in a rodent model of
malaria showed that induction of heme oxygenase I in
neutrophils during acute malarial anaemia resulted in loss
of function and was associated with increased susceptibil-
ity of mice to Salmonella typhimurium bacteraemia [16].
These observations have now been corroborated in chil-
dren with malaria showing that neutrophil dysfunction
was associated with parasite biomass and markers of
hemolysis [17].
We hypothesised that either translocation of endo-
toxin alone or translocation of gram-negative bacteria
and subsequent release of endotoxin into the blood
stream may play a role in pathogenesis of severe malaria
and its complications such as shock and organ dysfunc-
tion. We prospectively examined endotoxin levels
and its relationship to disease severity and cytokine




Between August and December 2009 paediatric admis-
sions to Kilifi District Hospital (KDH), Kenya with P. fal-
ciparum malaria and the acute paediatric ward at the
Mbale Regional Referral Hospital (MRRH), Eastern
Uganda were recruited. In Kilifi District malaria trans-
mission is now mesoendemic due to a steady decline in
transmission over the last 10 years [18]. In Mbale, mal-
aria occurs throughout the year and is consistent with
high stable transmission [19].
Three groups were considered based on the severity of
clinical symptoms: First, children hospitalised with P.
falciparum malaria with signs of severe illness but with-
out life-threatening clinical syndromes (n=51). Second,
children with severe, life-threatening malaria (n=206) in-
cluded children with respiratory distress (deep breathing
or indrawing), impaired consciousness (prostration or
coma) or severe anaemia (haemoglobin, Hb ≤5g/dl) [20].
The severe group was further subdivided into those with
(n=154) or without (n=52) shock (defined as at least one
of: severe tachycardia, delayed capillary refill (>2s),
temperature gradient or weak pulse) [21]. A proportion
of children (23 in Kilifi, 100 in Mbale) were recruited as
part of the FEAST study (Fluid Expansion as a Support-
ive Therapy) [21]. The third group, included 25 healthy
children who returned to KDH for a follow-up appoint-
ment four weeks after a severe malaria episode (healthy
control group). Clinical examination showed that these
children were afebrile and free of malaria parasites by
microscopy.
Malaria was diagnosed by a rapid malaria test (DiaMed
OptiMALW) and a blood film. In Mbale, parasite blood
films were screened for the presence of parasites but
parasite densities not reported whereas parasite densities
were reported in Kilifi. Clinical history, presentation and
laboratory values where recorded for all children using
the FEAST Case Report Form. Blood cultures were done
on all study participants in KDH but not in MRRH. At
KDH, only two children were blood culture positive
whereas in all other children no growth was reported.
Children presenting with severe anaemia (haemoglobin
≤5g/dl) were transfused 20mls/kg whole blood over
3 h. Moderate anaemia was defined as an Hb>5 and
≤7g/dl. All children received parenteral antimalarials
and antibiotics.
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The study was approved by the Ugandan Ethical Re-
view Committee (REIRC 002/2009) and the National
Ethical Review Committee in Kenya (SSC nos. 1135 and
1247). Parents or guardians of all children recruited to
take part in the study provided written informed
consent.
Endotoxin assay
We used an Endotoxin Activity Assay (EAA™ Spectral
Diagnostics) to detect the presence of endotoxin in
whole blood within 3 h of venepuncture according to
manufacturers instructions. This is a novel chemilumin-
escent assay that relies on the detection of Lipid A com-
ponent of lipopolysaccharide (LPS), which is not
susceptible to microbial contamination. It measures
endotoxin activity in whole blood by the priming of host
neutrophil respiratory burst activity via complement
opsonised LPS-IgM immune complexes and has shown
good correlation with Gram-negative infection and with
clinical sepsis, which was not apparent using limulus
amoebocyte lysate (LAL) assay [3,4]. The cut off value
for clinically relevant endotoxaemia, evaluated in the
MEDIC trial was 0.4 EAA Units (equivalent to an endo-
toxin concentration of 25–50 pg/ml of Escherichia coli
055:B5 LPS) with high endotoxin levels (at or above 0.6
EAA Units, equivalent to 200 pg/ml of Escherichia coli
055:B5 LPS) related to prognosis [4].
ELISA
Plasma was separated and stored in aliquots at -80C.
The cytokine concentration of TNFα, IL6, IL10, and
TGFβ was determined using Quantikine ELISA Kits
(R&D) according to the manufacturer’s instructions. The
plasma concentration of the intestinal fatty acid binding
protein (I-FABP) [22] was determined using an ELISA
kit from HyCult. The detection limits for all cytokines
were at or below 20 pg/ml.
Statistical Analysis
The presence or absence of clinical parameters in the
different study groups were determined using Pearson
χ2. Continuous values such as age and cytokine concen-
trations were compared between groups using the Mann
Whitney U test or Kruskal Wallis H test. Spearman’s rho
correlation coefficient was used to determine a relation-
ship between continuous variables. Statistical analyses
were performed using SPSS 18 (IBM SPSS Statistics)
and Stata version 11 (StataCorp LP).
Results
Clinical presentation of children with malaria
We recruited 257 children, 205 at MRRH and 52 at
KDH, the basic clinical presentation of all children is de-
scribed in Table 1. In the group with severe malaria,
Kenyan children were older, had a higher prevalence of
impaired consciousness and a lower prevalence of severe
anaemia or respiratory distress compared to children
recruited from MRRH, as expected in areas of lower
transmission intensity (Table 2). Blood culture data were
available for children admitted to KDH but only 2 cases
were blood culture positive. The only fatalities occurred
in the severe malaria cases with shock.
Children with malaria have elevated concentration of
endotoxin in their blood
Endotoxaemia (EAA≥0.4) was detected in 16 (31.4%)
children with non-severe malaria, 15 (28.3%) children
with severe malaria but not detected in any of the 25
healthy children recruited as a control group. The preva-
lence of endotoxaemia, in the subgroup of children with
severe malaria and shock was 40/154 (26%), with 3/10
(30%) in fatal cases and 37/144 (25.6%) in non-fatal cases
suggesting that the presence of endotoxaemia was nei-
ther associated with disease severity nor outcome.
The proportion of children with severe malaria com-
plicated by endotoxemia was lower in the cohort
recruited at KDH than in the cohort recruited at MRRH,
as was the number with high endotoxin levels (Table 2).
This could be due to either difference in age or trans-
mission intensity in these cohorts. We were unable to
show any relationship of age and endotoxin level within
each cohort (KDH: Spearman rho=−0.225, p=0.110;
MRRH: Spearman rho=−0.082, p=0.242). Nor did we
find any correlation between endotoxin levels and
parasite density in the 52 children with independently
verified malaria parasite quantification (Spearman
rho=−0.018; parasite density median (25th and 75th per-
centile): 183,280/ml (4,418-428,840/ml)).
Endotoxaemia and clinical presentation
Endotoxaemia (EAA≥0.4) was more likely to be present
in children with moderate anaemia (Hb>5 and ≤7g/dl)
or severe anaemia (Hb≤5g/dl) compared to children
without anaemia (Hb>7g/dl) (Table 3). By contrast,
endotoxaemia was less common in children with im-
paired consciousness than in those without altered
conscious level. However, this observation maybe con-
founded by the higher number of children presenting
with impaired consciousness at KDH who overall had a
lower prevalence of endotoxaemia. In order to exclude
this possibility we conducted a separate analysis of chil-
dren admitted to MRRH (n=205), which showed that
there was a similar prevalence of endotoxaemia in chil-
dren with impaired consciousness (27.1% (23/85)) com-
pared to those without impaired consciousness (34.2%
(41/120); Pearson χ2 = 1.17, p=0.299). We found no as-
sociation between endotoxin with other clinical sub-
groups or with outcome.
Olupot-Olupot et al. BMC Infectious Diseases 2013, 13:117 Page 3 of 9
http://www.biomedcentral.com/1471-2334/13/117
Association of endotoxaemia and cytokine level in
children with severe malaria
In critically ill patients, endotoxin acts as a potent
stimulus for the release of pro-inflammatory cytokines
followed by a phase of immune paralysis characterised
by control of inflammation. We speculated that children
with malaria and endotoxaemia could show either ele-
vated or depressed levels of pro-inflammatory cytokines.
Plasma concentrations of TNFα, IL6, IL10 and TGFβ are
presented in Table 4 by subgroup and outcome. Plasma
concentration of TNFα, IL6 and IL10 but not TGF β in-
creased with increasing disease severity (Table 4). Whilst
cytokine profiles were similar amongst children in differ-
ent subgroups of severe malaria, IL6, was higher in the
subgroup with shock (Mann Whitney U test, p<0.016).
Fatal cases had significantly higher plasma concentrations
of IL6 than those who survived (Mann Whitney U test
p=0.022).
Of note, in all subgroups of children with severe mal-
aria plasma concentrations of IL6, IL10 and TGFβ were
reduced in the presence of endotoxaemia compared to
those without endotoxaemia (Figure 1). Plasma endo-
toxin levels in severe malaria negatively correlated with
IL6, IL10 and TGFβ (Spearman rho: TNFα: r= −0.122,
p=0.121; IL6: r=−0.330, p<0.0001; IL10: r=−0.461,
p<0.0001; TGFβ: r=−0.173, p<0.027). Interestingly, the
plasma concentration of TNFα was not modified by
endotoxaemia (median TNFα (25th and 75th percentile)
with endotoxaemia: 0 pg/ml (0–54.3) without
endotoxaemia: 26.7 pg/ml (0–73.9) Mann Whitney U
test, p=0.2).
Intestinal fatty acid binding protein is increased in
children with malaria
We measured the plasma concentration of the intestinal
fatty acid binding protein (I-FABP), a marker for acute
enterocyte death and putative intestinal permeability, in
198 samples (Table 4). Neither the proportion of chil-
dren with detectable levels of I-FABP nor its median
plasma concentration differed between children with or
without endotoxaemia (Figure 2A). However, in children
with an I-FABP plasma concentration above 183 pg/ml
(Figure 2B) – a level that is currently indicated as being
associated with acute intestinal injury [23] - plasma
cytokine concentration of TNFα, IL6 and IL10 were sig-
nificantly higher in these children compared to those
without or lower concentrations of I-FABP.
Discussion
To our knowledge this is the first study to document the
prevalence of endotoxaemia in children suffering from
malaria. Approximately 30% of children with malaria
had detectable levels of endotoxin (LPS) in their blood.
Surprisingly, and contrary to findings in other critical
Table 1 Baseline clinical features of children with malaria
Non-severe malaria Severe malaria Severe malaria & shock P
Age (months)a 30.2 (15.5-52.8) 32.5 (14.8-57.6) 31.9 (14.8-48.2) 0.726
Impaired perfusionb 31.4% (16/51) - 100% (154/154) <0.0001
Respiratory distressb - 71.2% (37/52) 83.1% (128/154) 0.049
Impaired consciousnessb - 36.5% (19/52) 71.4% (110/154) <0.0001
Comab - 9.6% (5/52) 20.8% (32/154) 0.067
Severe anaemiab - 11.8% (6/51) 34.7% (52/150) 0.002
Mortality (48 h) b - 0% (0/52) 6.5% (10/154) -
Endotoxaemia (EAA≥0.4) b 31.4% (16/51) 28.3% (15/52) 26.0% (40/154) 0.738
High endotoxaemia (EAA≥0.6) b 9.8% (5/51) 5.8% (3/52) 10.4% (16/154) 0.608
a Shown are median and in parenthesis 25th and 75th percentile. For comparison of difference in age between groups, Kruskal-Wallis H test was used.
b Percentage of children presenting with syndrome and in parenthesis the number of children presenting with a syndrome over the total number of children in
that group. For comparison of the proportion of children presenting with a given syndrome, Pearson χ2 was used.
Table 2 Spectrum of clinical presentations of severe
malaria in children in Kilifi, Kenya and Mbale, Uganda
KDH MRRH P
Age (months)a 48.5 (37.6-70.7) 24 (13.1-42.3) <0.0001
Impaired perfusionb 79.2% (38/48) 73.2% (115/157) 0.410
Respiratory distressb 45.8% (22/48) 91.1% (143/157) <0.0001
Impaired consciousnessb 91.7% (44/48) 54.1% (85/157) <0.0001
Comab 31.3% (15/48) 14% (22/157) 0.007
Severe anaemiab 14.6% (7/48) 32.9% (50/152) 0.014
Mortality (48 h)b 4.2% (2/48) 5.1% (8/157) 0.794
Endotoxaemiab 12.5% (6/48) 31.2% (49/157) 0.01
High endotoxaemiab 2.1% (1/48) 11.5% (18/157) 0.05
a Shown are median and in parenthesis 25th and 75th percentile. For
comparison of difference in age between groups, Kruskal-Wallis H test
was used.
b Percentage of children presenting with syndrome and in parenthesis the
number of children presenting with a syndrome over the total number of
children in that group. For comparison of the proportion of children
presenting with a given syndrome, Pearson χ2 was used. Differences in
mortality were not calculated because all cases occurred in the group of
children with severe malaria and shock.
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illnesses but not all paediatric studies [6], we found
no evidence that endotoxaemia or high levels of
endotoxaemia (EAA> 0.6) were associated with the de-
gree of disease severity or led to a worse outcome. These
findings suggests that endotoxaemia may be important
in the transition of an uncomplicated episode of malaria
in children living in endemic regions to requiring hospi-
talisation but does not distinguish those at greatest risk
of life-threatening complications or organ dysfunction,
as in adults with severe sepsis [4].
In our study, the most notable clinical parameter asso-
ciated with endotoxaemia was anaemia. The origins of
malaria anaemia are multiple. Next to acute vascular
haemolysis of infected erythrocytes during acute malaria,
both acute and chronic infection cause inflammation
resulting in dyserythropoiesis due to changes in iron
storage metabolism and cytokine-mediated suppression
of the generation of progenitor cells [24-26]. It seems
unlikely that impaired oxygen delivery to the bowel as
a result of anaemia, directly causes endotoxaemia but
rather that inflammation is independently associated
with anaemia and increased gut permeability. Additional
evidence comes from studies in patients suffering from
sepsis and of endotoxaemia induced in human volun-
teers, which suggested that inflammation resulted in en-
terocyte death, increased gut permeability or both
[27,28]. I-FABP is particularly highly expressed in cells
present on the tips of the villi, the initial site of ischae-
mia reperfusion injury, indicating that circulating I-
FABP is a useful plasma marker for identifying bowel in-
jury secondary to splanchnic hypoperfusion [22]. This
association has been demonstrated in both murine and
human studies of ischaemia reperfusion injury [23,29].
We therefore tested the plasma concentration of I-FABP
in children with and without endotoxaemia. In our
study, I-FABP was detected in a similar proportion of
patients with or without endotoxaemia, contrary to the
findings in other studies [5]. However, we may have
missed a direct association between endotoxaemia and
I-FABP because the half-life of I-FABP is estimated to be
Table 3 Association of severe malaria clinical subgroups and endotoxaemia
n with endotoxin ≥ 0.4/N with clinical feature (%) χ2 Pa
Moderate anaemia Hb>7 g/dl 30/151 (19.9%)
Hb>5 and ≤7 g/dl 14/40 (34.4%) 4.084 0.043
Severe anaemia Hb>7 g/dl 30/151 (19.9%)
Hb≤5 g/dl 24/58 (41.4%) 10.12 0.001
Any anaemia Hb>7 g/dl 30/151 (19.9%)
Hb≤7 g/dl 38/98 (38.8%) 10.7 0.001
Impaired consciousness None 43/128 (33.6%)
Prostration or Coma 28/129 (21.7%) 4.5 0.033
Respiratory distress None 27/92 (29.3%)
Presentb 44/165 (26.7%) 0.21 0.645
Shock None 32/106 (30.2%)
Shock 39/151 (25.8%) 0.592 0.442
Mortality Non-fatal 68/247 (27.5%)
Fatal 3/10 (30%) 0.03 0.864
a Pearson χ2 with 1° of freedom and corresponding P value.
bDeep breathing or Indrawing.
Table 4 Plasma cytokine concentrations in children with different disease severity
Non-severe malaria Severe malaria Severe malaria & shock Fatal cases Pa
N 44 30 126 10
TNFα (pg/ml)b 0 (0–19.3) 0 (0–59.3) 28.8 (0–70) 0 (0–115) 0.014
IL6 (pg/ml)b 0 (0–20.8) 0 (0–82) 52.5 (0–219) 524 (30–1252) <0.0001
IL10 (pg/ml)b 105 (0–373) 211 (59–744) 471 (135–1159) 492 (62–1924) 0.002
TGFβ (pg/ml)b 467 (83–1371) 453 (0–938) 510 (0–1101) 793 (0–1037) 0.499
I-FABP (pg/ml)b,c 0 (0–205) 0 (0–429) 0 (0–310) 218 (0–1138) 0.217
aKruskal Wallis H test.
bShown are median and 25th and 75th percentile.
cThe plasma concentration of I-FABP was measured in 43 children with non-severe malaria, 30 children with severe malaria, 116 children with severe malarial
shock and 9 fatal cases.
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11 min [30] and plasma I-FABP concentrations reflect
immediate enterocyte damage rather than recent cell
damage. By contrast, pathological concentrations of
I-FABP were associated with increased plasma concentra-
tions of TNFα, IL6 and IL10 suggesting that at least in a
proportion of children, enterocytes and thus the gut
barrier function are damaged due to inflammation.
We hypothesised that the most likely source of
endotoxaemia is the gastrointestinal tract. Gastro-intestinal
symptoms are common in malaria yet there has been little
recent interest in gut barrier dysfunction despite evidence
provided over 2–3 decades ago demonstrating histopatho-
logical changes and impaired absorption [13,14,31,32].
Histopathological studies have demonstrated intense se-
questration of P. falciparum-infected erythrocytes within
the endothelial bed of the gut, particularly at the tip of in-
testinal villi [13,14] and the presence of small bowel intus-
susceptions in children with severe malaria [15] has been
reported. The central pathological processes of falciparum
malaria include increased rigidity (or non-deformability) of
non-parasitized red cells [33] and intense sequestration of
late stage infected erythrocytes in venules and capillaries-
both of which compromise microcirculatory flow to vital
organs and alter endothelial cell function [34]. Sequestra-
tion may favour direct translocation of gram-negative
bacteria or, through induction of inflammation, lead
to injury and an impaired gut barrier function with the
transfer of endotoxin and/or pathogenic bacteria into the
blood stream.
Sequestration is mediated by parasite molecules
expressed on the surface of infected erythrocytes that
mediate their adhesion to receptor expressed on endo-
thelial cells [35]. Interestingly, infected erythrocytes from
children suffering from severe anaemia usually show re-
duced adhesion to these receptors [36,37] which may in-
crease the release of inflammatory cytokines in these
patients [38] providing another link between inflamma-
tion and anaemia. In addition, during acute blood stage
malaria TLR agonists such as parasite DNA and GPI are
released [39,40] and may increase responsiveness of leu-
kocytes to secondary challenge with TLR ligands, at least
in uncomplicated malaria [41,42]. Both factors inde-
pendently increase inflammation and may lead to
inflammation-induced anaemia and loss of gut barrier
function resulting in the translocation of endotoxin and/
or bacteria into the blood stream.
Together these data suggest that parasite-mediated
sequestration and inflammation contribute to both an-
aemia and changes in gut permeability. However, par-
ticularly TLR-mediated induction of inflammation leads
to altered responsiveness of leukocytes to additional
signals such as endotoxin-tolerance. In our study,














Figure 1 Scatterplot of plasma cytokine concentrations in all children suffering from severe malaria with or without endotoxaemia
(EAA >0.4 units). Differences in the plasma cytokine concentration in children with or without endotoxaemia were determined using Mann
Whitney U tests and significant differences are indicated with p<0.0001 for IL6 and IL10 (**) and p<0.05 for TGFβ (*). Horizontal bars represent
the median.
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endotoxaemia was associated with decreased plasma
concentrations of TNFα, IL6 and IL10 compared to
those without endotoxaemia [43]. In sepsis, it has been
shown that patients may enter a phase of immune-
paralysis signified by control of inflammation, alternate
signalling pathways in leukocytes and enhanced apop-
tosis of immune effector cells [44]. Although the control
of inflammatory responses reduces organ damage and
early mortality, it comes at the expense of increased vul-
nerability to infection due to either activation of latent
viruses or secondary infection with pathogens and in-
creased risk of mortality [44-46]. Thus, endotoxin-
mediated depression of inflammatory immune responses
may contribute to decreased ability of malaria patients
to control secondary bacterial infection.
There is strong evidence that recent or current infec-
tion with malaria increases the risk of systemic bacterial
infection with high associated mortality rates in several
sub-Saharan countries [8,9,11,47,48]. Of note, a study in
Tanzanian children with recent or current malaria dem-
onstrated that one of the key bedside predictors of IBD
(largely NTS and other Gram-negative organisms) was
severe anaemia [12]. Recent studies suggested that that
the association between NTS and anaemia may be due
to changes in neutrophil function as a result of changes
in iron storage metabolism and subsequently inefficient
control of pathogenic bacteria once they have entered
the blood stream [17].
Our study is limited by the absence of blood culture data
and parasite density data, which were available only for a
very small number of children. All but one child with blood
culture data were negative for gram-negative organisms
suggesting that endotoxaemia resulted from endotoxin
translocation due to gut barrier dysfunction. Despite the
small number of children with blood culture data, this ap-
pears plausible since the prevalence of endotoxin observed
in this study was much higher than previous reports of bac-
terial co-infection, which are in the order of 5-12% [8-12];
but this is confounded by the low sensitivity of blood cul-
ture and preadmission antibiotic use. Furthermore, we
measured endotoxaemia and plasma cytokines only at
admission of children with acute disease and therefore
can only speculate on the link between endotoxaemia,
inflammation and subsequent immune-paralysis. Repeat
sampling from the early stages of infection through to
acute illness and resolution of malaria would be required
to elucidate the complex interactions of inflammatory
pathways and their regulation.
Conclusions
We suggest the following hypothesis: A proportion of
children suffering from malaria experience loss of the
barrier function of the gut due to parasite sequestration
(and reduced microcirculatory flow), inflammation or
both. This could be augmented by other pathophysio-
logical processes, specific to falciparum malaria includ-
ing severe anaemia and those leading to microvascular
obstruction. In some children, loss of gut barrier func-
tion might be sufficient to allow translocation of endo-
toxin and translocation of gram-negative bacteria with
subsequent release of endotoxin into the bloodstream.
Endotoxin and other TLR–ligands expressed by gram-
negative bacteria could further increase malaria-induced
inflammation followed by regulatory immune responses
that result in temporary immune paralysis as has been
described for sepsis. Then children, having entered a

























Figure 2 Endotoxin levels and cytokine concentrations in
children with increased plasma -concentration of I-FABP. Shown
are scatter plots of endotoxin EAA Unit (A) and plasma cytokine
concentration (B) in children with malaria and plasma I-FABP
concentration above or below 183 pg/ml. Differences in the plasma
cytokine concentration in children with or without increased plasma
I-FABP were determined using Mann Whitney U tests and significant
differences are indicated with p<0.001 for IL6 and IL10 (**) and
p<0.05 for TGFβ (*). Horizontal bars represent the median.
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an adequate immune response controlling bacteraemia.
This hypothesis is testable through investigation of gut-
barrier function in children suffering from malaria, char-
acterisation of the cytoadhesion profile of clinical parasite
isolates from children with malaria and endotoxaemia and
by analysing differences in the innate and adaptive im-
mune response pathways in children with severe malaria
in the presence or absence of endotoxaemia.
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